Overall, the studies reviewed by the committee did not show any persuasive evidence of associations between HD and exposure to specific solvents or solvent mixtures. Although many of the studies of exposure to mixtures of solvents yielded increased risk estimates, there was considerable statistical variability in them. The incidence of HD is low, and most studies had small numbers of exposed cases to evaluate. Having such small numbers may lead to spuriously increased relative risks when the null hypothesis of no association is true. That limitation is reflected in the wide CIs observed in most of the studies. The lack of specific or validated exposure-assessment information and the impact of bias are other limitations that the committee considered in drawing its conclusion. Table 6.36 identifies the key studies reviewed for each exposure and the data points evaluated by the committee. Unless indicated in the tables, the study populations include both men and women.
The committee concludes, from its assessment of the epidemiologic literature, that there is inadequate/insufficient evidence to determine whether an association exists between chronic exposure to solvents under review and Hodgkin’s disease.
TABLE 6.36 Selected Epidemiologic Studies—Hodgkin’s Disease and Exposure to Organic Solvents
|
Reference |
Study Population |
Exposed Cases |
Estimated Relative Risk (95% CI) |
|
Trichloroethylene |
|||
|
Cohort Study—Incidence |
|||
|
Anttila et al., 1995 |
Biologically monitored workers in Finland |
3 |
1.70 (0.35–4.96) |
|
|
<100 µmol/L |
2 |
2.00 (0.24–7.22) |
|
|
≥100 µmol/L |
1 |
1.83 (0.05–10.2) |
|
Cohort Studies—Mortality |
|||
|
Boice et al., 1999 |
Aircraft-manufacturing workers in California, potential routine exposure |
4 |
2.77 (0.76–7.10) |
|
Blair et al., 1998 |
Aircraft-maintenance workers in Utah, employed >1 year |
5 |
1.4 (0.2–12.0) |
|
Morgan et al., 1998 |
Aerospace workers in Arizona |
|
|
|
|
All exposed |
1 |
0.60 (0.02–3.35) |
|
|
Low exposure |
1 |
1.55 (0.04–8.64) |
|
|
High exposure |
0 |
— |
|
Axelson et al., 1994 |
Biologically monitored male workers in Sweden |
1 |
1.07 (0.03–5.95) |
|
Case-Control Study |
|||
|
Persson et al., 1989 |
Residents of Sweden, exposed >1 year |
7 |
2.8 (0.96–7.86)a |
|
Benzene |
|||
|
Cohort Study—Mortality |
|||
|
Wong, 1987a,b |
US male chemical-plant workers |
3 |
0.81 (0.16–2.36) |
|
|
Benzene, continuously exposed |
2 |
1.12 (0.14–4.05) |
|
|
Not exposed to benzene |
1 |
0.75 (0.19–4.15) |
|
|
Duration of exposure, continuously exposed to benzene: |
|
|
|
|
<5 years |
1 |
0.88 |
|
|
5–14 years |
1 |
2.37 |
|
|
≥15 years |
0 |
— |